TP53 and cancer: We note that a re-analysis of cell lines curated in the Catalogue Of Somatic Mutations In Cancer (COSMIC) database revealed that bi-allelic loss of TP53 and RB1 can also be detected in a subset of human NSCLC cancer cell lines (Fig. S5F).